UAS Laboratories

UAS Laboratories

Global leader in probiotic innovation. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD134—201m (Dealroom.co estimates Jan 2019.)
United States (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$21.2m

Seed
N/A

$21.7m

Late VC

N/A

Acquisition
Total FundingAUD66.3m

Recent News about UAS Laboratories

Edit
More about UAS Laboratoriesinfo icon
Edit

UAS Labs, established in 1979, specializes in the development and manufacturing of scientifically proven probiotic solutions aimed at enhancing wellness and quality of life. Operating in the global health and wellness market, UAS Labs serves a diverse range of clients including healthcare providers, dietary supplement companies, and companion animal health businesses. The company's business model revolves around the production and distribution of high-quality probiotic strains that have been clinically studied for their benefits to the immune system and gastrointestinal health. Revenue is generated through the sale of these probiotic products under various brands and through contract manufacturing services. UAS Labs is committed to innovation, leveraging scientific research to ensure the efficacy and safety of its products. The company also places a strong emphasis on quality and employs a team of dedicated professionals to maintain its industry-leading standards.

Keywords: probiotics, wellness, immune support, gastrointestinal health, dietary supplements, companion animals, clinical studies, contract manufacturing, innovation, quality.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.